4basebio (LSE:4BB) Ending Cash Position : £3.56 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is 4basebio Ending Cash Position?

4basebio's Ending Cash Position for the quarter that ended in Jun. 2023 was £3.56 Mil.

4basebio's quarterly Ending Cash Position declined from Jun. 2022 (£5.60 Mil) to Dec. 2022 (£4.35 Mil) and declined from Dec. 2022 (£4.35 Mil) to Jun. 2023 (£3.56 Mil).

4basebio's annual Ending Cash Position declined from Dec. 2020 (£15.00 Mil) to Dec. 2021 (£9.59 Mil) and declined from Dec. 2021 (£9.59 Mil) to Dec. 2022 (£4.35 Mil).

4basebio Ending Cash Position Historical Data

The historical data trend for 4basebio's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Ending Cash Position Chart

4basebio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

0.08

15.00

9.59

4.35

4basebio Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Ending Cash Position	Get a 7-Day Free Trial			12.06	9.59	5.60	4.35	3.56

4basebio Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

4basebio's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	9.586	+	-5.235
	=	4.35

4basebio's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4.351	+	-0.793
	=	3.56

4basebio Ending Cash Position Related Terms

Thank you for viewing the detailed overview of 4basebio's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (LSE:4BB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

88Q:Germany

Address

25 Norman Way, Over, Cambridge, GBR, CB24 5QE

Website

https://www.4basebio.com

4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (LSE:4BB) Headlines

No Headlines